| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |